[go: up one dir, main page]

MX2022013264A - Vacuna contra el coronavirus. - Google Patents

Vacuna contra el coronavirus.

Info

Publication number
MX2022013264A
MX2022013264A MX2022013264A MX2022013264A MX2022013264A MX 2022013264 A MX2022013264 A MX 2022013264A MX 2022013264 A MX2022013264 A MX 2022013264A MX 2022013264 A MX2022013264 A MX 2022013264A MX 2022013264 A MX2022013264 A MX 2022013264A
Authority
MX
Mexico
Prior art keywords
materials
transportation
present disclosure
storage
packaging
Prior art date
Application number
MX2022013264A
Other languages
English (en)
Inventor
Özlem Türeci
Ugur Sahin
Andreas Kuhn
Annette Vogel
Alexander Muik
Kerstin Walzer
Sonja Witzel
Alptekin Güler
Stephanie Hein
Marjoh Nauta
Dirk Jozef Peeters
Doorslaer Tom Frank Steven Van
Advait Vijay Badkar
Ramin Darvari
Nicholas William Warne
James Jean
Danny Pierre G Hendrikse
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2022013264A publication Critical patent/MX2022013264A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/02—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents specially adapted to protect contents from mechanical damage
    • B65D81/05—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents specially adapted to protect contents from mechanical damage maintaining contents at spaced relation from package walls, or from other contents
    • B65D81/127—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents specially adapted to protect contents from mechanical damage maintaining contents at spaced relation from package walls, or from other contents using rigid or semi-rigid sheets of shock-absorbing material
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
    • F25D3/00—Devices using other cold materials; Devices using cold-storage bodies
    • F25D3/12—Devices using other cold materials; Devices using cold-storage bodies using solidified gases, e.g. carbon-dioxide snow
    • F25D3/125—Movable containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D77/00—Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
    • B65D77/04—Articles or materials enclosed in two or more containers disposed one within another
    • B65D77/0413—Articles or materials enclosed in two or more containers disposed one within another the inner and outer containers being rigid or semi-rigid and the outer container being of polygonal cross-section formed by folding or erecting one or more blanks, e.g. carton
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/38—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents with thermal insulation
    • B65D81/3813—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents with thermal insulation rigid container being in the form of a box, tray or like container
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
    • F25D29/00—Arrangement or mounting of control or safety devices
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/08—Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
    • G06Q10/083—Shipping
    • G06Q10/0832—Special goods or special handling procedures, e.g. handling of hazardous or fragile goods
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/08—Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
    • G06Q10/083—Shipping
    • G06Q10/0833—Tracking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20223—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
    • F25D2303/00—Details of devices using other cold materials; Details of devices using cold-storage bodies
    • F25D2303/08—Devices using cold storage material, i.e. ice or other freezable liquid
    • F25D2303/082—Devices using cold storage material, i.e. ice or other freezable liquid disposed in a cold storage element not forming part of a container for products to be cooled, e.g. ice pack or gel accumulator
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
    • F25D2331/00—Details or arrangements of other cooling or freezing apparatus not provided for in other groups of this subclass
    • F25D2331/80—Type of cooled receptacles
    • F25D2331/812—Trays
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
    • F25D2700/00—Means for sensing or measuring; Sensors therefor
    • F25D2700/12—Sensors measuring the inside temperature

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Economics (AREA)
  • Microbiology (AREA)
  • Combustion & Propulsion (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Thermal Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Marketing (AREA)
  • General Physics & Mathematics (AREA)
  • Human Resources & Organizations (AREA)
  • Development Economics (AREA)
  • Operations Research (AREA)
  • Quality & Reliability (AREA)
  • Strategic Management (AREA)
  • Tourism & Hospitality (AREA)
  • General Business, Economics & Management (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Theoretical Computer Science (AREA)

Abstract

La presente descripción se refiere a los campos de envasado, transporte y almacenamiento de materiales sensibles a la temperatura, tales como productos biológicos y/o farmacéuticos. En este documento se proporcionan diversos aspectos de dicho envasado, transporte y almacenamiento para materiales de temperatura ultrabaja útiles para el tratamiento y/o prevención de enfermedades. La presente descripción también proporciona materiales de envasado, métodos de transporte y métodos de almacenamiento para mantener los materiales biológicos y/o farmacéuticos a temperaturas ultrabajas para mantener la integridad de los materiales. La presente divulgación se relaciona además con el campo del ARN para prevenir o tratar la infección por coronavirus.
MX2022013264A 2020-04-22 2021-04-16 Vacuna contra el coronavirus. MX2022013264A (es)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
EP2020061239 2020-04-22
EP2020066968 2020-06-18
EP2020068174 2020-06-26
EP2020069805 2020-07-13
EP2020071733 2020-07-31
EP2020071839 2020-08-03
EP2020073668 2020-08-24
EP2020081544 2020-11-09
EP2020081981 2020-11-12
EP2020082601 2020-11-18
EP2020082989 2020-11-20
EP2020083435 2020-11-25
EP2020084342 2020-12-02
US202063120977P 2020-12-03 2020-12-03
EP2020085145 2020-12-08
EP2020085653 2020-12-10
EP2020087844 2020-12-23
EP2021050027 2021-01-04
EP2021050874 2021-01-15
EP2021050875 2021-01-15
EP2021051772 2021-01-26
EP2021052572 2021-02-03
EP2021052716 2021-02-04
EP2021054622 2021-02-24
PCT/EP2021/060004 WO2021213945A1 (en) 2020-04-22 2021-04-16 Coronavirus vaccine

Publications (1)

Publication Number Publication Date
MX2022013264A true MX2022013264A (es) 2023-01-24

Family

ID=75497942

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022013264A MX2022013264A (es) 2020-04-22 2021-04-16 Vacuna contra el coronavirus.

Country Status (11)

Country Link
US (1) US20240002127A1 (es)
EP (1) EP4139616A1 (es)
JP (1) JP2023526178A (es)
KR (1) KR20230015351A (es)
CN (1) CN115843330A (es)
AU (1) AU2021260750A1 (es)
BR (1) BR112022019793A2 (es)
CA (1) CA3176481A1 (es)
IL (1) IL297414A (es)
MX (1) MX2022013264A (es)
WO (1) WO2021213945A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA47016A (fr) 2015-10-22 2018-08-29 Modernatx Inc Vaccins contre les virus respiratoires
US12194089B2 (en) 2020-02-04 2025-01-14 CureVac SE Coronavirus vaccine
CN115811986A (zh) 2020-04-22 2023-03-17 生物技术欧洲股份公司 冠状病毒疫苗
KR20230164648A (ko) 2020-12-22 2023-12-04 큐어백 에스이 SARS-CoV-2 변이체에 대한 RNA 백신
EP4277653A1 (en) * 2021-01-15 2023-11-22 ModernaTX, Inc. Variant strain-based coronavirus vaccines
AU2022208057A1 (en) * 2021-01-15 2023-08-03 Modernatx, Inc. Variant strain-based coronavirus vaccines
WO2022200623A1 (en) * 2021-03-25 2022-09-29 Schott Ag Pharmaceutical container
EP4319803B1 (en) 2021-04-08 2025-11-26 Vaxthera SAS Coronavirus vaccine comprising a mosaic protein
US20240321387A1 (en) 2021-05-04 2024-09-26 BioNTech SE Immunogen selection
EP4145132A1 (en) * 2021-09-03 2023-03-08 ISAR Bioscience GmbH Methods and kit for determining the antibody status and t-cell immunity against sars-cov-2
US12186387B2 (en) 2021-11-29 2025-01-07 BioNTech SE Coronavirus vaccine
CN119563028A (zh) 2022-05-12 2025-03-04 尚威天成信使核糖核酸治疗公司 具有分泌抗原和免疫调节物的合成自扩增mRNA分子
WO2024002985A1 (en) 2022-06-26 2024-01-04 BioNTech SE Coronavirus vaccine
WO2024064385A1 (en) 2022-09-23 2024-03-28 Bloodhound Tracking Device, Inc. Tracking system and tracking device
WO2024089638A1 (en) 2022-10-28 2024-05-02 Glaxosmithkline Biologicals Sa Nucleic acid based vaccine
CN116139108B (zh) * 2023-04-23 2023-08-01 威瑞生物科技(昆明)有限责任公司 一种脂质递送系统及其所构成的类病毒结构疫苗
EP4611348A3 (en) * 2024-03-01 2025-10-29 Bloodhound Tracking Device, Inc. Method and system for managing tracking devices
JP7646133B1 (ja) 2024-04-19 2025-03-17 医療法人すぎやま内科 乳がん細胞の増殖抑制剤及び乳がん治療剤
US12252325B1 (en) 2024-07-15 2025-03-18 Ember Lifesciences, Inc. Reusable portable shipping container

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292817A (en) * 1980-05-12 1981-10-06 The Mead Corporation Controlled temperature shipping assembly
US4474033A (en) * 1983-06-06 1984-10-02 Baker John F Passive transportable cooling unit for storing vials of allergenic extracts or the like
US4898278A (en) * 1986-12-05 1990-02-06 Nalge Company Storage container
JPH10113117A (ja) * 1996-10-11 1998-05-06 Tomoji Tanaka 保冷箱
DE69801094D1 (de) * 1997-12-23 2001-08-16 Edwin Francis Tattam Isoliertransportbehälter
US6381981B1 (en) * 2001-05-02 2002-05-07 Advanced Tissue Sciences, Inc. Container for shipping and storing frozen products
US6519968B1 (en) * 2001-05-09 2003-02-18 Loctite Corporation Shipping container for exothermic material
US20030082357A1 (en) * 2001-09-05 2003-05-01 Cem Gokay Multi-layer core for vacuum insulation panel and insulated container including vacuum insulation panel
US6494336B1 (en) * 2001-10-17 2002-12-17 The United States Of America As Represented By The Secretary Of The Navy Modular combat load system
US20050178142A1 (en) * 2004-02-17 2005-08-18 Perry Ralph J. 96 hour duration insulated cryo-pack for maintaining -40 degree fahrenheit
US7310967B2 (en) * 2004-02-20 2007-12-25 Aragon Daniel M Temperature controlled container
US7870748B2 (en) * 2005-02-25 2011-01-18 Byrne Kathleen H Method for controlled rate freezing and long term cryogenic storage
US20110255644A1 (en) * 2005-12-05 2011-10-20 Seldon Technologies, Inc. METHODS OF GENERATING NON-IONIZING RADIATION OR NON-IONIZING 4He USING GRAPHENE BASED MATERIALS
US8794013B2 (en) * 2006-02-10 2014-08-05 Praxair Technology, Inc. Method and system for nucleation control in a controlled rate freezer (CRF)
EP1996053B1 (en) * 2006-03-02 2015-12-30 Cold Chain Technologies, Inc. Insulated shipping container and method of making the same
US20100162734A1 (en) * 2008-12-29 2010-07-01 Linde, Inc. Self-Chilling Container
EP2281579A1 (en) 2009-08-05 2011-02-09 BioNTech AG Vaccine composition comprising 5'-Cap modified RNA
US8763811B2 (en) * 2011-05-05 2014-07-01 Gary Lantz Insulated shipping container, and method of making
EP2869842A1 (en) * 2012-07-06 2015-05-13 Novartis AG Immunogenic compositions and uses thereof
US9060508B2 (en) * 2012-07-18 2015-06-23 Alex N. Anti High-performance extended target temperature containers
US10618695B2 (en) * 2012-11-16 2020-04-14 Savsu Technologies Llc Contents rack for use in insulated storage containers
SG11201508518UA (en) * 2013-04-22 2015-11-27 Theranos Inc Methods, devices, and systems for secure transport of materials
EP3003024A4 (en) * 2013-06-03 2017-04-26 Biocision, LLC Cryogenic systems
DE102014106197A1 (de) * 2014-05-05 2015-11-05 Schott Ag Verfahren zum Verpacken einer Mehrzahl von Behältern für Substanzen für medizinische, pharmazeutische oder kosmetische Anwendungen sowie Verpackungsstruktur
WO2016005004A1 (en) 2014-07-11 2016-01-14 Biontech Rna Pharmaceuticals Gmbh Stabilization of poly(a) sequence encoding dna sequences
GB201502260D0 (en) * 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
US9963287B2 (en) * 2015-09-08 2018-05-08 Ekopak, Inc. Insulated shipping system
WO2017059902A1 (en) 2015-10-07 2017-04-13 Biontech Rna Pharmaceuticals Gmbh 3' utr sequences for stabilization of rna
GB2546257A (en) * 2016-01-08 2017-07-19 The Wool Packaging Company Ltd Temperature controlled packaging and transportation method
WO2017143540A1 (zh) * 2016-02-24 2017-08-31 松冷（武汉）科技有限公司 一种保温箱、运输装置及运输方法
GB201611050D0 (en) * 2016-06-24 2016-08-10 Softbox Systems Ltd A passive temperature control system for transport and storage containers
FI127108B (en) * 2016-10-12 2017-11-15 Vakava Tech Ltd Oy Adjusting the temperature at the target volume position
KR20190122725A (ko) * 2017-02-23 2019-10-30 베리쿨, 인코포레이티드 단열 패키징
US10443918B2 (en) * 2017-05-18 2019-10-15 Otter Products, Llc Configurable insulated storage container
US10619907B2 (en) * 2017-05-31 2020-04-14 Keith A. Kenneally Refrigerated, thermally insulated, collapsible cover system, assembly and method of using to transport perishable products
IT201700111328A1 (it) * 2017-10-04 2019-04-04 Bellco Srl Secondary packaging container and method for hemodialysis dialyzers
EP3698092A4 (en) * 2017-10-16 2021-08-25 American Aerogel Corporation SUBDIVIDED SHIPPING CONTAINER FOR DISTRIBUTION OF TEMPERATURE CONTROL MATERIAL

Also Published As

Publication number Publication date
CA3176481A1 (en) 2021-10-28
EP4139616A1 (en) 2023-03-01
CN115843330A (zh) 2023-03-24
AU2021260750A1 (en) 2022-11-24
BR112022019793A2 (pt) 2022-12-13
WO2021213945A1 (en) 2021-10-28
US20240002127A1 (en) 2024-01-04
IL297414A (en) 2022-12-01
KR20230015351A (ko) 2023-01-31
JP2023526178A (ja) 2023-06-21

Similar Documents

Publication Publication Date Title
MX2022013264A (es) Vacuna contra el coronavirus.
US6270723B1 (en) Rapid cryobaric sterilization and vaccine preparation
RU2440825C2 (ru) Жидкая фармацевтическая композиция ботулинического токсина
US6696019B2 (en) Rapid cryobaric sterilization and vaccine preparation
Hemati et al. The correlation between the presence of quorum sensing, toxin-antitoxin system genes and MIC values with ability of biofilm formation in clinical isolates of Pseudomonas aeruginosa
US10632188B2 (en) Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof
ATE243198T1 (de) Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen
Kapadia et al. Preoperative blood management strategies for total knee arthroplasty
Nguyen et al. Cold atmospheric plasma is a viable solution for treating orthopedic infection: a review
Guo et al. Immunostimulatory DNA hydrogel enhances protective efficacy of nanotoxoids against bacterial infection
CO2022012868A2 (es) Formulaciones de anticuerpos anti-tslp humanos y métodos de tratamiento de una enfermedad inflamatoria
BR112017028190A2 (pt) Peptídeo, peptídeo peguilado, composição, composição farmacêutica, frasco, solução de desinfecção, método para inibição de crescimento, replicação ou infectividade de um micro- organismo, método para inibição de crescimento bacteriano, método para inibição de replicação viral em uma célula, método para tratamento de uma infecção de micro-organismo em um sujeito e prevenção de uma doença em um sujeito causada por ou associada a uma infecção de micro- organismo, método para inibição de crescimento bacteriano em um sujeito, método para tratamento de uma infecção bacteriana em um sujeito e tratamento de uma doença causada por ou associada a uma infecção bacteriana, método para prevenção de uma doença causada por ou associada a uma infecção bacteriana em um sujeito, método para inibição de replicação viral em um sujeito, método para tratamento de uma infecção viral em um sujeito e tratamento de uma doença causada por ou associada a uma infecção viral em um sujeito, método para prevenção de uma doença causada por ou associada a uma infecção viral em um sujeito, método para desinfecção de um objeto inanimado ou material biológico e superfície inanimada ou superfície biológica
Scully et al. Immune responses to Methicillin-resistant Staphylococcus aureus infections and advances in the development of vaccines and immunotherapies
Rivalain et al. High hydrostatic pressure treatment for the inactivation of Staphylococcus aureus in human blood plasma
JP2022526542A (ja) 液体組成物中の生モリクテス綱細菌の安定化
PH12023550246A1 (en) Modified chikungunya viruses and sindbis viruses and uses thereof
Kovalev et al. Effect of cryopreserved cord blood serum and placental extract on cold-wound healing
CN109069614A (zh) 用改进的制剂使甲病毒稳定的组合物和方法
BR112014008464A2 (pt) composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo
MX2024001085A (es) Proteccion de especies biologicas contra la degradacion.
RU2720423C1 (ru) Способ защиты овощных культур от инфекций, вызываемых вирусами
CN105274063B (zh) 高滴度hiv-1毒种的制备方法
Giles Ultrasound and shockwave therapy for acute fractures in adults
Hinchcliffe et al. Using Synthetic Biology to Improve Global Vaccine Distribution
Ross VACCINATIONS: RESEARCH, DEVELOPMENT AND MANUFACTURING